123 related articles for article (PubMed ID: 32539794)
1. Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study.
Vallée Marcotte B; Allaire J; Guénard F; de Toro-Martín J; Couture P; Lamarche B; Vohl MC
Genes Nutr; 2020 Jun; 15(1):10. PubMed ID: 32539794
[TBL] [Abstract][Full Text] [Related]
2. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
3. Fine mapping of genome-wide association study signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation.
Vallée Marcotte B; Guénard F; Lemieux S; Couture P; Rudkowska I; Calder PC; Minihane AM; Vohl MC
Am J Clin Nutr; 2019 Jan; 109(1):176-185. PubMed ID: 30624603
[TBL] [Abstract][Full Text] [Related]
4. Genetic Risk Score Predictive of the Plasma Triglyceride Response to an Omega-3 Fatty Acid Supplementation in a Mexican Population.
Vallée Marcotte B; Guénard F; Marquis J; Charpagne A; Vadillo-Ortega F; Tejero ME; Binia A; Vohl MC
Nutrients; 2019 Mar; 11(4):. PubMed ID: 30934900
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
6. Update of a Genetic Risk Score Predictive of the Plasma Triglyceride Response to an Omega-3 Fatty Acid Supplementation in the FAS Study.
Gauthier E; de Toro-Martín J; Vallée-Marcotte B; Lemieux S; Rudkowska I; Couture P; Vohl MC
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904157
[TBL] [Abstract][Full Text] [Related]
7. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.
Rudkowska I; Guénard F; Julien P; Couture P; Lemieux S; Barbier O; Calder PC; Minihane AM; Vohl MC
J Lipid Res; 2014 Jul; 55(7):1245-53. PubMed ID: 24847101
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil.
Ramprasath VR; Eyal I; Zchut S; Shafat I; Jones PJ
Lipids Health Dis; 2015 Nov; 14():142. PubMed ID: 26537218
[TBL] [Abstract][Full Text] [Related]
11. Effect of prenatal EPA and DHA on maternal and cord blood insulin sensitivity: a secondary analysis of the mothers, omega 3, and mental health study.
England JA; Jain J; Holbrook BD; Schrader R; Qualls C; Mozurkewich E
BMC Pregnancy Childbirth; 2019 Nov; 19(1):452. PubMed ID: 31783739
[TBL] [Abstract][Full Text] [Related]
12. Models predict change in plasma triglyceride concentrations and long-chain n-3 polyunsaturated fatty acid proportions in healthy participants after fish oil intervention.
Potter TIT; Horgan GW; Wanders AJ; Zandstra EH; Zock PL; Fisk HL; Minihane AM; Calder PC; Mathers JC; de Roos B
Front Nutr; 2022; 9():989716. PubMed ID: 36386924
[TBL] [Abstract][Full Text] [Related]
13. Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study.
Allaire J; Vors C; Harris WS; Jackson KH; Tchernof A; Couture P; Lamarche B
Br J Nutr; 2019 Jun; 121(11):1223-1234. PubMed ID: 30854986
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial.
Tremblay BL; Cormier H; Rudkowska I; Lemieux S; Couture P; Vohl MC
Lipids Health Dis; 2015 Feb; 14():12. PubMed ID: 25889305
[TBL] [Abstract][Full Text] [Related]
16. Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
Nissen SE; Lincoff AM; Wolski K; Ballantyne CM; Kastelein JJP; Ridker PM; Ray KK; McGuire DK; Mozaffarian D; Koenig W; Davidson MH; Garcia M; Katona BG; Himmelmann A; Loss LE; Poole M; Menon V; Nicholls SJ
JAMA Cardiol; 2021 May; 6(8):1-8. PubMed ID: 33993205
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
18. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
Cao J; Schwichtenberg KA; Hanson NQ; Tsai MY
Clin Chem; 2006 Dec; 52(12):2265-72. PubMed ID: 17053155
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
[TBL] [Abstract][Full Text] [Related]
20. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
